Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriela Alexe

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Leukemia|January 8, 2026
Identifying targeted therapies for CBFA2T3::GLIS2 acute myeloid leukemiaFanny Gonzales, Constanze Schneider, Gabriela Alexe, et al.
The Journal of Experimental Medicine|July 27, 2018
Genome-scale CRISPR-Cas9 screen identifies druggable dependencies in <i>TP53</i> wild-type Ewing sarcomaBjörn Stolte, Amanda Balboni Iniguez, Neekesh V Dharia, et al.
High-Throughput|December 11, 2019
Descriptors for High Throughput in Structural Materials DevelopmentMatthias Steinbacher, Gabriela Alexe, Michael Baune, et al.
Cancer Cell|February 15, 2014
SYK is a critical regulator of FLT3 in acute myeloid leukemiaAlexandre Puissant, Nina Fenouille, Gabriela Alexe, et al.
Leukemia|August 3, 2021
Targeting serine hydroxymethyltransferases 1 and 2 for T-cell acute lymphoblastic leukemia therapyYana Pikman, Nicole Ocasio-Martinez, Gabriela Alexe, et al.
International Journal of Cancer|March 7, 2018
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemiaStefano Baldoni, Beatrice Del Papa, Erica Dorillo, et al.
Immunity|September 24, 2013
Antigen availability determines CD8⁺ T cell-dendritic cell interaction kinetics and memory fate decisionsSarah E Henrickson, Mario Perro, Scott M Loughhead, et al.
Cancer Cell|January 24, 2018
EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing SarcomaAmanda Balboni Iniguez, Björn Stolte, Emily Jue Wang, et al.
Molecular Cancer Research : MCR|March 19, 2026
Inhibition of USP7 destabilizes the noncanonical PRC1.1 complex and induces neuroblastoma differentiationEmily A Cmarik, Abhishek Wahi, Sayali S Chandekar, et al.
Cancer Discovery|February 23, 2013
Targeting MYCN in neuroblastoma by BET bromodomain inhibitionAlexandre Puissant, Stacey M Frumm, Gabriela Alexe, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Leukemia|January 8, 2026
Identifying targeted therapies for CBFA2T3::GLIS2 acute myeloid leukemiaFanny Gonzales, Constanze Schneider, Gabriela Alexe, et al.
The Journal of Experimental Medicine|July 27, 2018
Genome-scale CRISPR-Cas9 screen identifies druggable dependencies in <i>TP53</i> wild-type Ewing sarcomaBjörn Stolte, Amanda Balboni Iniguez, Neekesh V Dharia, et al.
High-Throughput|December 11, 2019
Descriptors for High Throughput in Structural Materials DevelopmentMatthias Steinbacher, Gabriela Alexe, Michael Baune, et al.
Cancer Cell|February 15, 2014
SYK is a critical regulator of FLT3 in acute myeloid leukemiaAlexandre Puissant, Nina Fenouille, Gabriela Alexe, et al.
Leukemia|August 3, 2021
Targeting serine hydroxymethyltransferases 1 and 2 for T-cell acute lymphoblastic leukemia therapyYana Pikman, Nicole Ocasio-Martinez, Gabriela Alexe, et al.
International Journal of Cancer|March 7, 2018
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemiaStefano Baldoni, Beatrice Del Papa, Erica Dorillo, et al.
Immunity|September 24, 2013
Antigen availability determines CD8⁺ T cell-dendritic cell interaction kinetics and memory fate decisionsSarah E Henrickson, Mario Perro, Scott M Loughhead, et al.
Cancer Cell|January 24, 2018
EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing SarcomaAmanda Balboni Iniguez, Björn Stolte, Emily Jue Wang, et al.
Molecular Cancer Research : MCR|March 19, 2026
Inhibition of USP7 destabilizes the noncanonical PRC1.1 complex and induces neuroblastoma differentiationEmily A Cmarik, Abhishek Wahi, Sayali S Chandekar, et al.
Cancer Discovery|February 23, 2013
Targeting MYCN in neuroblastoma by BET bromodomain inhibitionAlexandre Puissant, Stacey M Frumm, Gabriela Alexe, et al.
Pageof 9